SNCA and Parkinson disease: Recently, we have demonstrated the potential of α-synuclein shRNA-MCs (syn-MCs) loaded into mouse RVG-EVs to induce long-term down-regulation of α-synuclein expression in the brains of α-synuclein performed fibril (PFF) mouse model of PD [19].